Stroke Trial, Recruiting NCT07610850 Sponsor: Ecole Polytechnique Fédérale de Lausanne Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07610850
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 70 years old at the time of joining the trial.
  • People who have had a stroke affecting the deeper parts of the brain (including the brain stem) that happened at least 9 months ago but no more than 10 years ago.
  • People whose upper limb movement scores below 25 on a standardised arm movement scale called the Fugl-Meyer upper-limb scale.
  • People who are able to stand, with or without a walking aid, for at least 30 seconds.
  • People who score above 22 on a standardised memory and thinking assessment called the Montreal Cognitive Assessment.
  • People who have weakness or paralysis affecting one side of the body (either left or right).
  • People who have already completed their standard rehabilitation treatment.
  • People who are willing and able to sign an informed consent form before any study procedures begin.
  • People who can understand and communicate with the study team in either French or English.
  • People who agree to follow all study conditions and attend all scheduled appointments.
  • Women who are able to become pregnant and agree to use effective contraception throughout the study.
  • People who are able to temporarily stop taking blood-thinning or anti-clotting medications around the time of any surgeries involved in the study, if applicable.

Who may not be able to join:

  • People who are currently pregnant or breastfeeding.
  • People who plan to become pregnant during the study period.
  • People who have health conditions that would increase the risks associated with implantation surgery.
  • People who have been assessed by a psychologist as having mental health instability, including a diagnosed personality disorder, psychosis, substance abuse issues, or severe depression.
  • People who have other medical conditions that the trial investigators determine would prevent them from taking part in testing (for example, major cognitive disorders, kidney failure, liver problems, or epilepsy).
  • People who have significant ongoing difficulty swallowing, problems with food or liquid entering the airway, or who require a ventilator to breathe.
  • People who have an active implanted device already in their body, such as a pacemaker or another nerve stimulator.
  • People who have spinal abnormalities or physical incompatibilities that would make the implant surgery impossible or unsafe.
  • People who have severe muscle stiffness (spasticity) in their arm or leg, scoring above 3 on a scale called the Modified Ashworth Scale.
  • People who need to have frequent MRI scans for any ongoing medical reason.
  • People who are currently participating in another clinical study involving drugs or medical devices that could affect this study's results.
  • People who are investigators on this study, or their family members, employees, or others in a dependent relationship with them.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jocelyne Bloch, MD, CHUV

Phone: +41 79 556 29 51

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ecole Polytechnique Fédérale de Lausanne
Registry
ClinicalTrials.gov
Start date
1 September 2026
Est. completion
1 October 2028

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Preliminary safety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov